Gabelli Funds LLC reduced its stake in shares of AMETEK, Inc. (NYSE:AME – Free Report) by 4.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 830,313 shares of the technology company’s stock after selling 37,600 shares during the quarter. AMETEK comprises about 1.4% of Gabelli Funds LLC’s investment portfolio, making the stock its 4th largest holding. Gabelli Funds LLC’s holdings in AMETEK were worth $205,693,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also bought and sold shares of the stock. Meeder Advisory Services Inc. raised its position in shares of AMETEK by 11.2% during the 3rd quarter. Meeder Advisory Services Inc. now owns 6,157 shares of the technology company’s stock worth $1,525,000 after buying an additional 621 shares in the last quarter. Benjamin Edwards Inc. boosted its holdings in shares of AMETEK by 1.4% in the third quarter. Benjamin Edwards Inc. now owns 5,123 shares of the technology company’s stock valued at $1,269,000 after acquiring an additional 72 shares in the last quarter. Jackson Thornton Wealth Management LLC boosted its holdings in shares of AMETEK by 18.2% in the third quarter. Jackson Thornton Wealth Management LLC now owns 2,365 shares of the technology company’s stock valued at $586,000 after acquiring an additional 365 shares in the last quarter. E Fund Management Hong Kong Co. Ltd. boosted its holdings in shares of AMETEK by 628.8% in the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 430 shares of the technology company’s stock valued at $107,000 after acquiring an additional 371 shares in the last quarter. Finally, Sumitomo Life Insurance Co. increased its stake in shares of AMETEK by 0.7% during the third quarter. Sumitomo Life Insurance Co. now owns 9,988 shares of the technology company’s stock valued at $2,474,000 after acquiring an additional 73 shares during the period. Institutional investors and hedge funds own 87.43% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on AME shares. Royal Bank Of Canada boosted their target price on AMETEK from $291.00 to $308.00 and gave the stock an “outperform” rating in a report on Wednesday, November 4th. Truist Financial reaffirmed a “buy” rating and set a $329.00 price target (up from $316.00) on shares of AMETEK in a research note on Friday, November 13th. Morgan Stanley set a $275.00 price target on AMETEK in a research note on Friday, October 9th. BNP Paribas Exane lifted their price target on AMETEK from $280.00 to $290.00 and gave the company an “outperform” rating in a research report on Friday, September 11th. Finally, Rothschild & Co Redburn boosted their price objective on AMETEK from $265.00 to $275.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $278.88.
View Our Latest Report on AMETEK
Trending Headlines about AMETEK
These are some of the AME headlines that stood out recently:
- Positive Sentiment: A third-party roundup described AMETEK as a standout among companies reporting IoT-sector results, offering some positive industry context, though it provided no new company-specific guidance. Article: Internet of Things Q3 earnings: AMETEK simply the best
- Neutral Sentiment: AMETEK completed a $2.1 billion multi-currency senior-notes offering, including $500 million of 5.550% notes due 2031. The financing may support corporate needs, but adds debt and interest obligations; the available report excerpt does not specify how proceeds will be used. Article: AMETEK Completes $2.1 Billion Multi-Currency Senior Notes Offering
- Negative Sentiment: Zacks Research trimmed several future EPS forecasts, including FY2027 from $9.58 to $9.52 and FY2028 from $10.66 to $10.35. The cuts are modest, and Zacks still rates AMETEK “Strong Buy,” but lower projections may weigh on investor expectations. Article: FY2026 Earnings Estimate for AMETEK Issued By Zacks Research
AMETEK Price Performance
Shares of NYSE AME opened at $222.73 on Friday. AMETEK, Inc. has a twelve month low of $190.25 and a twelve month high of $261.16. The company has a current ratio of 1.43, a quick ratio of 0.91 and a debt-to-equity ratio of 0.52. The firm has a 50-day moving average of $242.91 and a two-hundred day moving average of $235.25. The company has a market capitalization of $51.08 billion, a price-to-earnings ratio of 31.41, a PEG ratio of 1.99 and a beta of 0.96.
AMETEK (NYSE:AME – Get Free Report) last announced its quarterly earnings data on Tuesday, November 3rd. The technology company reported $2.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.11 by $0.10. AMETEK had a net margin of 19.91% and a return on equity of 17.12%. The company had revenue of $2.22 billion for the quarter, compared to analysts’ expectations of $2.12 billion. During the same quarter in the previous year, the company posted $1.89 EPS. The business’s revenue was up 17.3% compared to the same quarter last year. As a group, analysts expect that AMETEK, Inc. will post 8.57 earnings per share for the current fiscal year.
AMETEK Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 18th. Investors of record on Friday, December 4th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Friday, December 4th. AMETEK’s dividend payout ratio (DPR) is presently 19.18%.
AMETEK Profile
AMETEK, Inc. is a global manufacturer of electronic instruments and electromechanical products. Its businesses serve a range of markets, including aerospace, energy, industrial manufacturing, medical, and transportation. The company’s products include analytical and process instruments, monitoring and measurement systems, aerospace components, precision motors and pumps, and engineered materials. AMETEK organizes its operations into two groups: Electronic Instruments and Electromechanical. Founded in 1930, AMETEK serves customers around the world through manufacturing facilities, sales offices, and service operations in multiple countries.
Featured Stories
- Five stocks we like better than AMETEK
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME – Free Report).
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.
